CSL (ASX: CSL.AX ): profits hit by strong dollar, one-off contribution from sale of pandemic flu vaccine

CSL (ASX: CSL.AX ) : profits hit by strong dollar, one-off contribution from sale of pandemic flu vaccine


From the announcement:

"CSL Limited today announced a profit after tax of $500 million for the six months ended 31 December 2010.

This result included an unfavourable foreign exchange impact of
$47 million. Net profit after tax in the prior comparable period was $617 million, which included a one-off contribution from the sale of pandemic influenza vaccine (H1N1)."

According to Dr McNamee, CSL’s Managing Director, the "success of our novel A (H1N1) influenza or ‘swine flu’ vaccine, Panvax®, in the
prior comparable period was a one-off contribution and, as foreshadowed, resulted in a decline in our headline profit."

CSL Intermim release available via this link:
http://www.csl.com.au/s1/cs/auhq/1187378853299/news/1255925859621/prdetail.htm